nodes	percent_of_prediction	percent_of_DWPC	metapath
Epirubicin—Onycholysis—Ramipril—type 1 diabetes mellitus	0.039	0.0812	CcSEcCtD
Epirubicin—Alopecia reversible—Ramipril—type 1 diabetes mellitus	0.0233	0.0484	CcSEcCtD
Epirubicin—CHD1—retina—type 1 diabetes mellitus	0.019	0.0832	CbGeAlD
Epirubicin—PLA2G4A—Enalapril—Ramipril—type 1 diabetes mellitus	0.0189	1	CbGdCrCtD
Epirubicin—CHD1—nephron tubule—type 1 diabetes mellitus	0.0179	0.0783	CbGeAlD
Epirubicin—Polyneuropathy—Ramipril—type 1 diabetes mellitus	0.0162	0.0337	CcSEcCtD
Epirubicin—CHD1—pancreas—type 1 diabetes mellitus	0.0156	0.0684	CbGeAlD
Epirubicin—DHCR7—islet of Langerhans—type 1 diabetes mellitus	0.015	0.0656	CbGeAlD
Epirubicin—YWHAG—islet of Langerhans—type 1 diabetes mellitus	0.0138	0.0602	CbGeAlD
Epirubicin—CHD1—lymphoid tissue—type 1 diabetes mellitus	0.0135	0.0591	CbGeAlD
Epirubicin—DHCR7—retina—type 1 diabetes mellitus	0.0128	0.0561	CbGeAlD
Epirubicin—Doxorubicin—NOS1—type 1 diabetes mellitus	0.0127	0.483	CrCbGaD
Epirubicin—AURKA—kidney—type 1 diabetes mellitus	0.0127	0.0555	CbGeAlD
Epirubicin—DHCR7—nephron tubule—type 1 diabetes mellitus	0.0121	0.0528	CbGeAlD
Epirubicin—YWHAG—retina—type 1 diabetes mellitus	0.0118	0.0515	CbGeAlD
Epirubicin—Kidney function abnormal—Ramipril—type 1 diabetes mellitus	0.0109	0.0227	CcSEcCtD
Epirubicin—AURKA—lymphoid tissue—type 1 diabetes mellitus	0.0109	0.0477	CbGeAlD
Epirubicin—Peripheral vascular disorder—Ramipril—type 1 diabetes mellitus	0.0108	0.0224	CcSEcCtD
Epirubicin—DHCR7—pancreas—type 1 diabetes mellitus	0.0105	0.0461	CbGeAlD
Epirubicin—YWHAG—cardiovascular system—type 1 diabetes mellitus	0.00995	0.0435	CbGeAlD
Epirubicin—YWHAG—kidney—type 1 diabetes mellitus	0.00974	0.0426	CbGeAlD
Epirubicin—YWHAG—pancreas—type 1 diabetes mellitus	0.00967	0.0423	CbGeAlD
Epirubicin—DHCR7—lymphoid tissue—type 1 diabetes mellitus	0.00911	0.0399	CbGeAlD
Epirubicin—UGT2B7—kidney—type 1 diabetes mellitus	0.00879	0.0385	CbGeAlD
Epirubicin—Psoriasis—Ramipril—type 1 diabetes mellitus	0.0084	0.0175	CcSEcCtD
Epirubicin—YWHAG—lymphoid tissue—type 1 diabetes mellitus	0.00836	0.0366	CbGeAlD
Epirubicin—Parosmia—Ramipril—type 1 diabetes mellitus	0.00814	0.0169	CcSEcCtD
Epirubicin—Bone marrow depression—Ramipril—type 1 diabetes mellitus	0.00782	0.0163	CcSEcCtD
Epirubicin—Burning sensation—Ramipril—type 1 diabetes mellitus	0.0076	0.0158	CcSEcCtD
Epirubicin—Neuralgia—Ramipril—type 1 diabetes mellitus	0.0076	0.0158	CcSEcCtD
Epirubicin—PLA2G4A—cardiovascular system—type 1 diabetes mellitus	0.00742	0.0325	CbGeAlD
Epirubicin—Doxorubicin—NOS3—type 1 diabetes mellitus	0.00691	0.263	CrCbGaD
Epirubicin—Doxorubicin—NOS2—type 1 diabetes mellitus	0.00667	0.254	CrCbGaD
Epirubicin—Ageusia—Ramipril—type 1 diabetes mellitus	0.00652	0.0136	CcSEcCtD
Epirubicin—Liver injury—Ramipril—type 1 diabetes mellitus	0.00628	0.0131	CcSEcCtD
Epirubicin—Jaundice cholestatic—Ramipril—type 1 diabetes mellitus	0.00601	0.0125	CcSEcCtD
Epirubicin—Cough increased—Ramipril—type 1 diabetes mellitus	0.00577	0.012	CcSEcCtD
Epirubicin—Glossitis—Ramipril—type 1 diabetes mellitus	0.00573	0.0119	CcSEcCtD
Epirubicin—Creatinine increased—Ramipril—type 1 diabetes mellitus	0.00555	0.0115	CcSEcCtD
Epirubicin—Hepatocellular injury—Ramipril—type 1 diabetes mellitus	0.00528	0.011	CcSEcCtD
Epirubicin—Salivary hypersecretion—Ramipril—type 1 diabetes mellitus	0.00513	0.0107	CcSEcCtD
Epirubicin—Blood urea increased—Ramipril—type 1 diabetes mellitus	0.00499	0.0104	CcSEcCtD
Epirubicin—Neuropathy—Ramipril—type 1 diabetes mellitus	0.00496	0.0103	CcSEcCtD
Epirubicin—Rash maculo-papular—Ramipril—type 1 diabetes mellitus	0.0048	0.00998	CcSEcCtD
Epirubicin—Photosensitivity—Ramipril—type 1 diabetes mellitus	0.00437	0.00908	CcSEcCtD
Epirubicin—Vascular purpura—Ramipril—type 1 diabetes mellitus	0.00429	0.00891	CcSEcCtD
Epirubicin—Hepatic failure—Ramipril—type 1 diabetes mellitus	0.00427	0.00887	CcSEcCtD
Epirubicin—Renal failure acute—Ramipril—type 1 diabetes mellitus	0.00415	0.00864	CcSEcCtD
Epirubicin—Dermatitis exfoliative—Ramipril—type 1 diabetes mellitus	0.00406	0.00845	CcSEcCtD
Epirubicin—Renal impairment—Ramipril—type 1 diabetes mellitus	0.00403	0.00838	CcSEcCtD
Epirubicin—Purpura—Ramipril—type 1 diabetes mellitus	0.00398	0.00827	CcSEcCtD
Epirubicin—Anaphylactoid reaction—Ramipril—type 1 diabetes mellitus	0.00396	0.00824	CcSEcCtD
Epirubicin—Hypoglycaemia—Ramipril—type 1 diabetes mellitus	0.00393	0.00817	CcSEcCtD
Epirubicin—Cardiac failure—Ramipril—type 1 diabetes mellitus	0.00393	0.00817	CcSEcCtD
Epirubicin—Cerebrovascular accident—Ramipril—type 1 diabetes mellitus	0.00391	0.00814	CcSEcCtD
Epirubicin—Hyponatraemia—Ramipril—type 1 diabetes mellitus	0.00385	0.00801	CcSEcCtD
Epirubicin—Blood creatinine increased—Ramipril—type 1 diabetes mellitus	0.00359	0.00747	CcSEcCtD
Epirubicin—Liver function test abnormal—Ramipril—type 1 diabetes mellitus	0.00354	0.00736	CcSEcCtD
Epirubicin—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.0035	0.00728	CcSEcCtD
Epirubicin—Abdominal pain upper—Ramipril—type 1 diabetes mellitus	0.0035	0.00728	CcSEcCtD
Epirubicin—Breast disorder—Ramipril—type 1 diabetes mellitus	0.00346	0.00721	CcSEcCtD
Epirubicin—Toxic epidermal necrolysis—Ramipril—type 1 diabetes mellitus	0.00345	0.00718	CcSEcCtD
Epirubicin—Gastritis—Ramipril—type 1 diabetes mellitus	0.00339	0.00706	CcSEcCtD
Epirubicin—Asthma—Ramipril—type 1 diabetes mellitus	0.00331	0.00689	CcSEcCtD
Epirubicin—Influenza—Ramipril—type 1 diabetes mellitus	0.00331	0.00689	CcSEcCtD
Epirubicin—Dysphagia—Ramipril—type 1 diabetes mellitus	0.00331	0.00689	CcSEcCtD
Epirubicin—Eosinophilia—Ramipril—type 1 diabetes mellitus	0.00328	0.00682	CcSEcCtD
Epirubicin—Pancreatitis—Ramipril—type 1 diabetes mellitus	0.00325	0.00676	CcSEcCtD
Epirubicin—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.00323	0.00671	CcSEcCtD
Epirubicin—Bronchitis—Ramipril—type 1 diabetes mellitus	0.00319	0.00663	CcSEcCtD
Epirubicin—Pancytopenia—Ramipril—type 1 diabetes mellitus	0.00315	0.00655	CcSEcCtD
Epirubicin—Neutropenia—Ramipril—type 1 diabetes mellitus	0.0031	0.00644	CcSEcCtD
Epirubicin—Upper respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.00308	0.00641	CcSEcCtD
Epirubicin—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.00302	0.00629	CcSEcCtD
Epirubicin—Weight increased—Ramipril—type 1 diabetes mellitus	0.00302	0.00627	CcSEcCtD
Epirubicin—Stevens-Johnson syndrome—Ramipril—type 1 diabetes mellitus	0.00293	0.00609	CcSEcCtD
Epirubicin—Renal failure—Ramipril—type 1 diabetes mellitus	0.0029	0.00604	CcSEcCtD
Epirubicin—Neuropathy peripheral—Ramipril—type 1 diabetes mellitus	0.0029	0.00602	CcSEcCtD
Epirubicin—Jaundice—Ramipril—type 1 diabetes mellitus	0.00288	0.00599	CcSEcCtD
Epirubicin—Stomatitis—Ramipril—type 1 diabetes mellitus	0.00288	0.00599	CcSEcCtD
Epirubicin—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.00287	0.00597	CcSEcCtD
Epirubicin—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.00287	0.00597	CcSEcCtD
Epirubicin—Sweating—Ramipril—type 1 diabetes mellitus	0.00283	0.00589	CcSEcCtD
Epirubicin—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.00279	0.00581	CcSEcCtD
Epirubicin—Epistaxis—Ramipril—type 1 diabetes mellitus	0.00279	0.0058	CcSEcCtD
Epirubicin—Sinusitis—Ramipril—type 1 diabetes mellitus	0.00277	0.00577	CcSEcCtD
Epirubicin—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.00276	0.00573	CcSEcCtD
Epirubicin—Hepatitis—Ramipril—type 1 diabetes mellitus	0.00265	0.00552	CcSEcCtD
Epirubicin—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.00261	0.00543	CcSEcCtD
Epirubicin—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.00261	0.00542	CcSEcCtD
Epirubicin—Visual impairment—Ramipril—type 1 diabetes mellitus	0.00256	0.00532	CcSEcCtD
Epirubicin—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.00251	0.00522	CcSEcCtD
Epirubicin—Tinnitus—Ramipril—type 1 diabetes mellitus	0.00247	0.00514	CcSEcCtD
Epirubicin—Flushing—Ramipril—type 1 diabetes mellitus	0.00246	0.00512	CcSEcCtD
Epirubicin—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.0024	0.00498	CcSEcCtD
Epirubicin—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.00239	0.00497	CcSEcCtD
Epirubicin—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.00237	0.00493	CcSEcCtD
Epirubicin—Alopecia—Ramipril—type 1 diabetes mellitus	0.00234	0.00487	CcSEcCtD
Epirubicin—Mental disorder—Ramipril—type 1 diabetes mellitus	0.00232	0.00483	CcSEcCtD
Epirubicin—Erythema—Ramipril—type 1 diabetes mellitus	0.00231	0.0048	CcSEcCtD
Epirubicin—Malnutrition—Ramipril—type 1 diabetes mellitus	0.00231	0.0048	CcSEcCtD
Epirubicin—Tension—Ramipril—type 1 diabetes mellitus	0.00227	0.00471	CcSEcCtD
Epirubicin—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.00226	0.0047	CcSEcCtD
Epirubicin—Nervousness—Ramipril—type 1 diabetes mellitus	0.00224	0.00466	CcSEcCtD
Epirubicin—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.00222	0.00462	CcSEcCtD
Epirubicin—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.00214	0.00446	CcSEcCtD
Epirubicin—Agitation—Ramipril—type 1 diabetes mellitus	0.00212	0.00441	CcSEcCtD
Epirubicin—Malaise—Ramipril—type 1 diabetes mellitus	0.00208	0.00433	CcSEcCtD
Epirubicin—Vertigo—Ramipril—type 1 diabetes mellitus	0.00207	0.00431	CcSEcCtD
Epirubicin—Syncope—Ramipril—type 1 diabetes mellitus	0.00207	0.00431	CcSEcCtD
Epirubicin—Leukopenia—Ramipril—type 1 diabetes mellitus	0.00207	0.0043	CcSEcCtD
Epirubicin—Palpitations—Ramipril—type 1 diabetes mellitus	0.00204	0.00424	CcSEcCtD
Epirubicin—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.00203	0.00422	CcSEcCtD
Epirubicin—Cough—Ramipril—type 1 diabetes mellitus	0.00201	0.00419	CcSEcCtD
Epirubicin—Convulsion—Ramipril—type 1 diabetes mellitus	0.002	0.00416	CcSEcCtD
Epirubicin—Myalgia—Ramipril—type 1 diabetes mellitus	0.00197	0.00409	CcSEcCtD
Epirubicin—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00197	0.00409	CcSEcCtD
Epirubicin—Chest pain—Ramipril—type 1 diabetes mellitus	0.00197	0.00409	CcSEcCtD
Epirubicin—Anxiety—Ramipril—type 1 diabetes mellitus	0.00196	0.00407	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.00195	0.00406	CcSEcCtD
Epirubicin—Discomfort—Ramipril—type 1 diabetes mellitus	0.00194	0.00404	CcSEcCtD
Epirubicin—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00192	0.004	CcSEcCtD
Epirubicin—Confusional state—Ramipril—type 1 diabetes mellitus	0.0019	0.00395	CcSEcCtD
Epirubicin—Oedema—Ramipril—type 1 diabetes mellitus	0.00188	0.00392	CcSEcCtD
Epirubicin—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.00188	0.00392	CcSEcCtD
Epirubicin—Shock—Ramipril—type 1 diabetes mellitus	0.00185	0.00386	CcSEcCtD
Epirubicin—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.00185	0.00384	CcSEcCtD
Epirubicin—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.00184	0.00384	CcSEcCtD
Epirubicin—Tachycardia—Ramipril—type 1 diabetes mellitus	0.00184	0.00383	CcSEcCtD
Epirubicin—Skin disorder—Ramipril—type 1 diabetes mellitus	0.00183	0.00381	CcSEcCtD
Epirubicin—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.00182	0.00379	CcSEcCtD
Epirubicin—YWHAG—Intrinsic Pathway for Apoptosis—CASP3—type 1 diabetes mellitus	0.0018	0.00734	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CASP12—type 1 diabetes mellitus	0.0018	0.00733	CbGpPWpGaD
Epirubicin—Anorexia—Ramipril—type 1 diabetes mellitus	0.0018	0.00374	CcSEcCtD
Epirubicin—Hypotension—Ramipril—type 1 diabetes mellitus	0.00176	0.00366	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00172	0.00357	CcSEcCtD
Epirubicin—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—NOS2—type 1 diabetes mellitus	0.00171	0.00696	CbGpPWpGaD
Epirubicin—UGT2B7—Phase II conjugation—GSTT1—type 1 diabetes mellitus	0.0017	0.00695	CbGpPWpGaD
Epirubicin—Insomnia—Ramipril—type 1 diabetes mellitus	0.0017	0.00354	CcSEcCtD
Epirubicin—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.00169	0.00352	CcSEcCtD
Epirubicin—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00168	0.00349	CcSEcCtD
Epirubicin—Somnolence—Ramipril—type 1 diabetes mellitus	0.00168	0.00348	CcSEcCtD
Epirubicin—PLA2G4A—Endothelins—PRKCQ—type 1 diabetes mellitus	0.00167	0.00683	CbGpPWpGaD
Epirubicin—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—VAV1—type 1 diabetes mellitus	0.00167	0.0068	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—VAV1—type 1 diabetes mellitus	0.00166	0.00678	CbGpPWpGaD
Epirubicin—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.00166	0.00345	CcSEcCtD
Epirubicin—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.00164	0.00341	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.00163	0.00338	CcSEcCtD
Epirubicin—Fatigue—Ramipril—type 1 diabetes mellitus	0.00162	0.00338	CcSEcCtD
Epirubicin—Constipation—Ramipril—type 1 diabetes mellitus	0.00161	0.00335	CcSEcCtD
Epirubicin—YWHAG—Calcium Regulation in the Cardiac Cell—ADRB1—type 1 diabetes mellitus	0.00161	0.00657	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—SST—type 1 diabetes mellitus	0.00156	0.00636	CbGpPWpGaD
Epirubicin—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00155	0.00323	CcSEcCtD
Epirubicin—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.00154	0.0032	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle—E2F1—type 1 diabetes mellitus	0.00151	0.00616	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet homeostasis—NOS1—type 1 diabetes mellitus	0.00151	0.00614	CbGpPWpGaD
Epirubicin—Urticaria—Ramipril—type 1 diabetes mellitus	0.0015	0.00311	CcSEcCtD
Epirubicin—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.00149	0.0031	CcSEcCtD
Epirubicin—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.00149	0.0031	CcSEcCtD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—E2F1—type 1 diabetes mellitus	0.00146	0.00594	CbGpPWpGaD
Epirubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—NOS1—type 1 diabetes mellitus	0.00144	0.00585	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—IL1R1—type 1 diabetes mellitus	0.0014	0.00572	CbGpPWpGaD
Epirubicin—YWHAG—Calcium Regulation in the Cardiac Cell—PRKCQ—type 1 diabetes mellitus	0.00139	0.00566	CbGpPWpGaD
Epirubicin—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00139	0.00289	CcSEcCtD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—E2F1—type 1 diabetes mellitus	0.00138	0.00561	CbGpPWpGaD
Epirubicin—YWHAG—Mitotic G2-G2/M phases—E2F1—type 1 diabetes mellitus	0.00137	0.00559	CbGpPWpGaD
Epirubicin—YWHAG—Role of Calcineurin-dependent NFAT signaling in lymphocytes—CASP3—type 1 diabetes mellitus	0.00136	0.00554	CbGpPWpGaD
Epirubicin—Asthenia—Ramipril—type 1 diabetes mellitus	0.00135	0.00281	CcSEcCtD
Epirubicin—TOP2A—Circadian rythm related genes—PRF1—type 1 diabetes mellitus	0.00135	0.00549	CbGpPWpGaD
Epirubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—PRKCQ—type 1 diabetes mellitus	0.00135	0.00548	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—PRKCQ—type 1 diabetes mellitus	0.00135	0.00548	CbGpPWpGaD
Epirubicin—Pruritus—Ramipril—type 1 diabetes mellitus	0.00133	0.00277	CcSEcCtD
Epirubicin—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00129	0.00268	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—SIRPG—type 1 diabetes mellitus	0.00128	0.00522	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—PTPN2—type 1 diabetes mellitus	0.00125	0.00508	CbGpPWpGaD
Epirubicin—Dizziness—Ramipril—type 1 diabetes mellitus	0.00125	0.00259	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle—CDK4—type 1 diabetes mellitus	0.00123	0.00502	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—IL1R1—type 1 diabetes mellitus	0.00122	0.00495	CbGpPWpGaD
Epirubicin—YWHAG—a6b1 and a6b4 Integrin signaling—EGFR—type 1 diabetes mellitus	0.0012	0.00489	CbGpPWpGaD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—E2F1—type 1 diabetes mellitus	0.0012	0.00489	CbGpPWpGaD
Epirubicin—Vomiting—Ramipril—type 1 diabetes mellitus	0.0012	0.00249	CcSEcCtD
Epirubicin—Rash—Ramipril—type 1 diabetes mellitus	0.00119	0.00247	CcSEcCtD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—CDK4—type 1 diabetes mellitus	0.00119	0.00484	CbGpPWpGaD
Epirubicin—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00119	0.00247	CcSEcCtD
Epirubicin—Headache—Ramipril—type 1 diabetes mellitus	0.00118	0.00246	CcSEcCtD
Epirubicin—TOP2A—Gastric Cancer Network 2—EGFR—type 1 diabetes mellitus	0.00113	0.00461	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.00113	0.0046	CbGpPWpGaD
Epirubicin—Nausea—Ramipril—type 1 diabetes mellitus	0.00112	0.00233	CcSEcCtD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—IL10—type 1 diabetes mellitus	0.00111	0.00453	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—E2F1—type 1 diabetes mellitus	0.00108	0.00441	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—IAPP—type 1 diabetes mellitus	0.00106	0.00431	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—FASLG—type 1 diabetes mellitus	0.00104	0.00423	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—NOS2—type 1 diabetes mellitus	0.00103	0.00419	CbGpPWpGaD
Epirubicin—UGT2B7—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000997	0.00406	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—HBA2—type 1 diabetes mellitus	0.000989	0.00403	CbGpPWpGaD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—type 1 diabetes mellitus	0.000978	0.00399	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—INS—type 1 diabetes mellitus	0.000942	0.00384	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—G6PC2—type 1 diabetes mellitus	0.00093	0.00379	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—IAPP—type 1 diabetes mellitus	0.000916	0.00373	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet homeostasis—NOS2—type 1 diabetes mellitus	0.000899	0.00366	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGF Pathway—STAT3—type 1 diabetes mellitus	0.000898	0.00366	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—SLC29A3—type 1 diabetes mellitus	0.000886	0.00361	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—NOS3—type 1 diabetes mellitus	0.000877	0.00357	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—ITPR3—type 1 diabetes mellitus	0.000871	0.00355	CbGpPWpGaD
Epirubicin—TOP2A—Mitotic G1-G1/S phases—E2F1—type 1 diabetes mellitus	0.000844	0.00344	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—NOS3—type 1 diabetes mellitus	0.000826	0.00337	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—ABCC8—type 1 diabetes mellitus	0.000806	0.00328	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—CASP3—type 1 diabetes mellitus	0.000788	0.00321	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet homeostasis—NOS3—type 1 diabetes mellitus	0.000723	0.00295	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—CASP3—type 1 diabetes mellitus	0.000701	0.00286	CbGpPWpGaD
Epirubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—NOS3—type 1 diabetes mellitus	0.000689	0.00281	CbGpPWpGaD
Epirubicin—TOP2A—Mitotic G1-G1/S phases—CDK4—type 1 diabetes mellitus	0.000688	0.00281	CbGpPWpGaD
Epirubicin—YWHAG—ErbB1 downstream signaling—STAT3—type 1 diabetes mellitus	0.000671	0.00273	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—E2F1—type 1 diabetes mellitus	0.00064	0.00261	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000637	0.0026	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—STAT3—type 1 diabetes mellitus	0.000626	0.00255	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—FASLG—type 1 diabetes mellitus	0.000615	0.0025	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—PRKCQ—type 1 diabetes mellitus	0.000614	0.0025	CbGpPWpGaD
Epirubicin—YWHAG—ErbB1 downstream signaling—EGFR—type 1 diabetes mellitus	0.00061	0.00248	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—EGFR—type 1 diabetes mellitus	0.000602	0.00245	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—VAV1—type 1 diabetes mellitus	0.000596	0.00243	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—STAT3—type 1 diabetes mellitus	0.000589	0.0024	CbGpPWpGaD
Epirubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—IL1B—type 1 diabetes mellitus	0.000586	0.00239	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—CASP3—type 1 diabetes mellitus	0.000585	0.00238	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—E2F1—type 1 diabetes mellitus	0.000584	0.00238	CbGpPWpGaD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—STAT3—type 1 diabetes mellitus	0.000584	0.00238	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—IL1B—type 1 diabetes mellitus	0.000583	0.00238	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—CASP3—type 1 diabetes mellitus	0.000582	0.00237	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—SELL—type 1 diabetes mellitus	0.000572	0.00233	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—EGFR—type 1 diabetes mellitus	0.000569	0.00232	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—E2F1—type 1 diabetes mellitus	0.000554	0.00226	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—IGF2—type 1 diabetes mellitus	0.00054	0.0022	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—ITPR3—type 1 diabetes mellitus	0.000538	0.00219	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	0.000537	0.00219	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—EGFR—type 1 diabetes mellitus	0.000536	0.00218	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—FASLG—type 1 diabetes mellitus	0.000532	0.00217	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—E2F1—type 1 diabetes mellitus	0.000522	0.00213	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—type 1 diabetes mellitus	0.000522	0.00213	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—HBA1—type 1 diabetes mellitus	0.000506	0.00206	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—APOC3—type 1 diabetes mellitus	0.000503	0.00205	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—CDK4—type 1 diabetes mellitus	0.000501	0.00204	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—GSTT1—type 1 diabetes mellitus	0.000494	0.00201	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—NOS2—type 1 diabetes mellitus	0.000487	0.00198	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—CDK4—type 1 diabetes mellitus	0.000476	0.00194	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	0.000465	0.0019	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	0.000455	0.00186	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—IL2RA—type 1 diabetes mellitus	0.000454	0.00185	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDK4—type 1 diabetes mellitus	0.000452	0.00184	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—type 1 diabetes mellitus	0.00045	0.00183	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—ITPR3—type 1 diabetes mellitus	0.000449	0.00183	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—E2F1—type 1 diabetes mellitus	0.000443	0.0018	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—CDK4—type 1 diabetes mellitus	0.000426	0.00174	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—TNF—type 1 diabetes mellitus	0.000425	0.00173	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—TNF—type 1 diabetes mellitus	0.000423	0.00172	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—SH2B3—type 1 diabetes mellitus	0.000423	0.00172	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—E2F1—type 1 diabetes mellitus	0.000396	0.00161	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—GCG—type 1 diabetes mellitus	0.000394	0.0016	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—IGF1—type 1 diabetes mellitus	0.000389	0.00159	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.000382	0.00156	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—CDK4—type 1 diabetes mellitus	0.000361	0.00147	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	0.000356	0.00145	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—STAT3—type 1 diabetes mellitus	0.000354	0.00144	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—IGF1—type 1 diabetes mellitus	0.000347	0.00141	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	0.000346	0.00141	CbGpPWpGaD
Epirubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—IL6—type 1 diabetes mellitus	0.000343	0.0014	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—IL6—type 1 diabetes mellitus	0.000341	0.00139	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—HBA2—type 1 diabetes mellitus	0.000341	0.00139	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—NOS1—type 1 diabetes mellitus	0.000338	0.00138	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—HBA2—type 1 diabetes mellitus	0.000335	0.00136	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—CAT—type 1 diabetes mellitus	0.000333	0.00136	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—ALB—type 1 diabetes mellitus	0.000328	0.00134	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	0.000328	0.00134	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	0.000325	0.00133	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—CDK4—type 1 diabetes mellitus	0.000323	0.00132	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—G6PC2—type 1 diabetes mellitus	0.000321	0.00131	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—PRKCQ—type 1 diabetes mellitus	0.000316	0.00129	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—G6PC2—type 1 diabetes mellitus	0.000315	0.00128	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—E2F1—type 1 diabetes mellitus	0.00031	0.00126	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.000309	0.00126	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—VAV1—type 1 diabetes mellitus	0.000307	0.00125	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.000305	0.00124	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.000305	0.00124	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.000305	0.00124	CbGpPWpGaD
Epirubicin—ABCC1—Disease—G6PC2—type 1 diabetes mellitus	0.0003	0.00122	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	0.0003	0.00122	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.000287	0.00117	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ABCC8—type 1 diabetes mellitus	0.000278	0.00113	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—IGF2—type 1 diabetes mellitus	0.000278	0.00113	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—E2F1—type 1 diabetes mellitus	0.000277	0.00113	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ABCC8—type 1 diabetes mellitus	0.000273	0.00111	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—HBA2—type 1 diabetes mellitus	0.000267	0.00109	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—IL2—type 1 diabetes mellitus	0.000266	0.00109	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	0.000264	0.00108	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.000258	0.00105	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CDK4—type 1 diabetes mellitus	0.000252	0.00103	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	0.000252	0.00103	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—G6PC2—type 1 diabetes mellitus	0.000251	0.00102	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.000241	0.000982	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—IL2RA—type 1 diabetes mellitus	0.000234	0.000954	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	0.000229	0.000933	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CDK4—type 1 diabetes mellitus	0.000226	0.00092	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—INS—type 1 diabetes mellitus	0.000221	0.000901	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—KCNJ11—type 1 diabetes mellitus	0.00022	0.000896	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ABCC8—type 1 diabetes mellitus	0.000218	0.000888	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	0.000218	0.000888	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000216	0.000879	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—SST—type 1 diabetes mellitus	0.000212	0.000862	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.000211	0.000858	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—ALB—type 1 diabetes mellitus	0.000203	0.000826	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—NOS2—type 1 diabetes mellitus	0.000201	0.000821	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—IL6—type 1 diabetes mellitus	0.000195	0.000794	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—NOS3—type 1 diabetes mellitus	0.000194	0.00079	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000189	0.000769	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ITPR3—type 1 diabetes mellitus	0.000186	0.000756	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000182	0.000743	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ITPR3—type 1 diabetes mellitus	0.000182	0.000742	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SLC11A1—type 1 diabetes mellitus	0.000182	0.000741	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000182	0.00074	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.00018	0.000735	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.00018	0.000735	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—IGF1—type 1 diabetes mellitus	0.000179	0.000728	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000176	0.000718	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000176	0.000716	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—HBA1—type 1 diabetes mellitus	0.000175	0.000712	CbGpPWpGaD
Epirubicin—ABCC1—Disease—ITPR3—type 1 diabetes mellitus	0.000174	0.000708	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—APOC3—type 1 diabetes mellitus	0.000174	0.000708	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000172	0.000702	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—HBA1—type 1 diabetes mellitus	0.000171	0.000698	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GSTT1—type 1 diabetes mellitus	0.000171	0.000695	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—APOC3—type 1 diabetes mellitus	0.00017	0.000694	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.00017	0.000691	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—ALB—type 1 diabetes mellitus	0.000169	0.00069	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GSTT1—type 1 diabetes mellitus	0.000167	0.000681	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IAPP—type 1 diabetes mellitus	0.000162	0.000662	CbGpPWpGaD
Epirubicin—ABCC1—Disease—APOC3—type 1 diabetes mellitus	0.000162	0.000662	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—NOS3—type 1 diabetes mellitus	0.000162	0.00066	CbGpPWpGaD
Epirubicin—ABCC1—Disease—B2M—type 1 diabetes mellitus	0.000156	0.000635	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	0.000154	0.000628	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000152	0.00062	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ITPR3—type 1 diabetes mellitus	0.000145	0.000593	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000143	0.000584	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000142	0.00058	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000142	0.00058	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—IL2—type 1 diabetes mellitus	0.000137	0.000559	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—HBA1—type 1 diabetes mellitus	0.000137	0.000558	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000136	0.000556	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—APOC3—type 1 diabetes mellitus	0.000136	0.000554	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GCG—type 1 diabetes mellitus	0.000136	0.000554	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000134	0.000548	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GSTT1—type 1 diabetes mellitus	0.000134	0.000544	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GCG—type 1 diabetes mellitus	0.000133	0.000543	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NOS1—type 1 diabetes mellitus	0.000131	0.000533	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SST—type 1 diabetes mellitus	0.000125	0.000509	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000124	0.000507	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	0.000123	0.000502	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PRKCQ—type 1 diabetes mellitus	0.000122	0.000499	CbGpPWpGaD
Epirubicin—ABCC1—Disease—VAV1—type 1 diabetes mellitus	0.000119	0.000484	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	0.000117	0.000477	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CAT—type 1 diabetes mellitus	0.000115	0.000469	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CAT—type 1 diabetes mellitus	0.000113	0.00046	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000111	0.000454	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000107	0.000437	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GCG—type 1 diabetes mellitus	0.000106	0.000434	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000104	0.000424	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000104	0.000423	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CD86—type 1 diabetes mellitus	0.000104	0.000422	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	9.47e-05	0.000386	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IGF2—type 1 diabetes mellitus	9.43e-05	0.000384	CbGpPWpGaD
Epirubicin—ABCC1—Disease—ERBB3—type 1 diabetes mellitus	9.34e-05	0.000381	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CCR5—type 1 diabetes mellitus	9.19e-05	0.000375	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CD86—type 1 diabetes mellitus	9.08e-05	0.00037	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CAT—type 1 diabetes mellitus	9.01e-05	0.000367	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HLA-A—type 1 diabetes mellitus	8.96e-05	0.000365	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—E2F1—type 1 diabetes mellitus	8.62e-05	0.000351	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	8.19e-05	0.000334	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCR5—type 1 diabetes mellitus	8.05e-05	0.000328	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	7.94e-05	0.000323	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL2—type 1 diabetes mellitus	7.88e-05	0.000321	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NOS2—type 1 diabetes mellitus	7.79e-05	0.000318	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—INS—type 1 diabetes mellitus	7.63e-05	0.000311	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CD80—type 1 diabetes mellitus	7.56e-05	0.000308	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—INS—type 1 diabetes mellitus	7.49e-05	0.000305	CbGpPWpGaD
Epirubicin—ABCC1—Disease—INS—type 1 diabetes mellitus	7.14e-05	0.000291	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ALB—type 1 diabetes mellitus	7e-05	0.000285	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ALB—type 1 diabetes mellitus	6.86e-05	0.00028	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—NOS3—type 1 diabetes mellitus	6.69e-05	0.000273	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CD80—type 1 diabetes mellitus	6.63e-05	0.00027	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—NOS3—type 1 diabetes mellitus	6.57e-05	0.000268	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TYK2—type 1 diabetes mellitus	6.38e-05	0.00026	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NOS3—type 1 diabetes mellitus	6.26e-05	0.000255	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—INS—type 1 diabetes mellitus	6.26e-05	0.000255	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IGF1—type 1 diabetes mellitus	6.06e-05	0.000247	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	6.03e-05	0.000246	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—INS—type 1 diabetes mellitus	5.98e-05	0.000244	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CD4—type 1 diabetes mellitus	5.77e-05	0.000235	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.59e-05	0.000228	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.49e-05	0.000224	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ALB—type 1 diabetes mellitus	5.48e-05	0.000223	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—NOS3—type 1 diabetes mellitus	5.25e-05	0.000214	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.66e-05	0.00019	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL2—type 1 diabetes mellitus	4.65e-05	0.00019	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.63e-05	0.000189	CbGpPWpGaD
Epirubicin—ABCC1—Disease—STAT3—type 1 diabetes mellitus	4.47e-05	0.000182	CbGpPWpGaD
Epirubicin—ABCC1—Disease—EGFR—type 1 diabetes mellitus	4.06e-05	0.000165	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.92e-05	0.00016	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.56e-05	0.000145	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IL6—type 1 diabetes mellitus	3.12e-05	0.000127	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL6—type 1 diabetes mellitus	2.74e-05	0.000111	CbGpPWpGaD
